Discover more insights into Dose Intensity 도즈 강도

Keywords frequently search together with Dose Intensity 도즈 강도

Narrow sentence examples with built-in keyword filters

Dose Intensity sentence examples within progression free survival



Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis


The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy

Dose Intensity sentence examples within relapse free survival



Incidence of Febrile Neutropenia in Advanced Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy in Korea and Its Impact on Prognosis


A Randomized Phase II Study of S-1 Adjuvant Chemotherapy With or Without Hochu-ekki-to, a Japanese Herbal Medicine, for Stage II/III Gastric Cancer: The KUGC07 (SHOT) Trial

Dose Intensity sentence examples within receive less relative



Symptom Experience, Management, and Outcomes According to Race and Social Determinants Including Genomics, Epigenomics, and Metabolomics (SEMOARS + GEM): an Explanatory Model for Breast Cancer Treatment Disparity


Abstract P1-17-10: The impact of age and adjuvant chemotherapy modifications on disease-free and overall survival among African American women with breast cancer



Dose Intensity sentence examples within modulated radiation therapy



Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation


High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity.

Dose Intensity sentence examples within Relative Dose Intensity



Real-World Therapeutic Outcomes of S-1 Adjuvant Chemotherapy for pStage II/III Gastric Cancer in the Elderly


The Role of Nanoliposomal Irinotecan Plus Fluorouracil and Folinic Acid as Second-Line Treatment Option in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Dose Intensity sentence examples within Median Dose Intensity



MDS-344: Pevonedistat Plus Azacitidine vs Azacitidine Alone in Higher-Risk Myelodysplastic Syndromes (MDS): Efficacy and Safety Results from Study P-2001 (NCT02610777)


The effect of body mass index on efficacy and safety of bosutinib or imatinib in patients with newly diagnosed chronic myeloid leukemia.

Dose Intensity sentence examples within Chemotherapy Dose Intensity



Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.


Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial

Dose Intensity sentence examples within Reduced Dose Intensity



Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review.


Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer.

Dose Intensity sentence examples within Received Dose Intensity



A Community Hospital-Based Study: A Prespecified Neutrophil Count with Adjuvant mFOLFOX6 Associated with Increased Delays, Increased G-CSF Use, and Reduced Dose Intensity


SMARTphone Based Cardiovascular Risk Reduction in BREAST Cancer Patients (SMART-BREAST): A Randomised Controlled Trial Protocol.

Dose Intensity sentence examples within Optimal Dose Intensity



Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer - Secondary analysis of the randomised phase 3 CONVERT trial.


Extensive-Stage Small Cell Carcinoma Transformation From EGFR Del19-Mutant Lung Adenocarcinoma on Gefitinib at the Twelfth-Year Follow-Up Case Report

Dose Intensity sentence examples within Radiation Dose Intensity



A Prospective Trial of Clinical Intuition to Predict Survival in Patients With Metastatic Cancer Referred to Radiation Oncology.


Association of radiation dose intensity with overall survival in patients with distant metastases.

Dose Intensity sentence examples within Maintain Dose Intensity



A cross-sectional study on the guideline adherence to antiemetic regimens for chemotherapy-induced nausea and vomiting: A single center retrospective study of 1000 patients.


A cross-sectional study on the effectiveness of antiemetic regimens for chemotherapy-induced nausea and vomiting: A single center retrospect study of 1,000 patients.

Dose Intensity sentence examples within Mean Dose Intensity



Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi


Safety and activity of single-agent giredestrant (GDC-9545) from a phase Ia/b study in patients (pts) with estrogen receptor-positive (ER+), HER2-negative locally advanced/metastatic breast cancer (LA/mBC).

Dose Intensity sentence examples within Lower Dose Intensity



Hodgkin lymphoma in the elderly: new perspectives and a 10‐year monocenter real‐life experience


Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3‐Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations

Dose Intensity sentence examples within Maintaining Dose Intensity



A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer


High‐Dose Chemotherapy in Relapsed or Refractory Metastatic Germ‐Cell Cancer: The Scotland Experience

Dose Intensity sentence examples within Increasing Dose Intensity



Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases.


Activity of epidermal growth factor tyrosine kinase inhibitors in non-small cell lung carcinoma with refractory leptomeningeal metastases.

Dose Intensity sentence examples within Planned Dose Intensity



Quality Assessment in Supportive Care in Head and Neck Cancer


Hematopoietic Growth Factors in the Management of Anemia and Febrile Neutropenia

Dose Intensity sentence examples within Mp Dose Intensity



The Effect of NUDT15, TPMT, APEX1, and ITPA Genetic Variations on Mercaptopurine Treatment of Pediatric Acute Lymphoblastic Leukemia


ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia

Dose Intensity sentence examples within Asparaginase Dose Intensity



How much asparaginase is needed for optimal outcome in childhood acute lymphoblastic leukaemia? A systematic review.


Effect of dose and schedule of L-asparaginase administration on early minimal residual disease in acute lymphoblastic leukemia

Dose Intensity sentence examples within Higher Dose Intensity



Effect of an Oncology Nurse-Led Primary Palliative Care Intervention on Patients With Advanced Cancer: The CONNECT Cluster Randomized Clinical Trial.


Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer

Dose Intensity sentence examples within Adequate Dose Intensity



Advances in treatment of elderly primary central nervous system lymphoma.


Treatment of elderly patients with primary CNS lymphoma

Dose Intensity sentence examples within Oxaliplatin Dose Intensity



Early-onset stage II/III colorectal adenocarcinoma in the IDEA database: Treatment adherence, toxicities, and outcomes from adjuvant fluoropyrimidine and oxaliplatin.


Clinical efficacy and safety of early adjuvant chemotherapy for stage III colon cancer: Short-term outcomes of a multicenter, randomized, open-label, phase 3 trial.

Dose Intensity sentence examples within dose intensity may



Effect of an Oncology Nurse-Led Primary Palliative Care Intervention on Patients With Advanced Cancer: The CONNECT Cluster Randomized Clinical Trial.


Dosing Schedules of Gemcitabine and nab-Paclitaxel for Older Adults With Metastatic Pancreatic Cancer


OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.


More Dose Intensity 도즈 강도 sentence examples
10.1200/JCO.2021.39.15_SUPPL.7009

Second-line bosutinib (BOS) for patients (pts) with chronic phase (CP) chronic myeloid leukemia (CML): Final 10-year results of a phase 1/2 study.



Effects of a 12-week multimodal exercise intervention among older patients with advanced cancer - results from a randomized controlled trial.



One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre



AML-248: Clinico-Pathological Profile of Therapy-Related Acute Myeloid Leukemia



Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report



Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases



Repercussions of radiotherapy to the metabolism and microbiome



Prophylaxis and treatment strategies for optimizing chemotherapy relative dose intensity



A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma



Reduced bendamustine for elderly patients with follicular lymphoma



High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study



Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers



A Novel Approach to Medical Management of Heart Failure with Reduced Ejection Fraction.



Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper



Oncologic Outcomes of Radical Prostatectomy and High-Dose Intensity-Modulated Radiotherapy with Androgen-Deprivation Therapy for Relatively Young Patients with Unfavorable Intermediate-Risk Prostate Adenocarcinoma



Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey



Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents



Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial



Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters



Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids



Survival and Predictive Factors of Chemotherapy With FOLFIRINOX as First-Line Therapy in Metastatic Pancreatic Cancer



Eribulin, Child-Pugh score, and liver-function tests: lessons from pivotal breast cancer studies 301 and 305



Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson’s disease, and correlates with levodopa equivalent daily dose



The influence of intervening on the pharmaceutical consultation targeting outpatients with advanced non-small cell lung cancer receiving erlotinib treatment.



The Influence of Adjuvant Chemotherapy Dose Intensity on Five-Year Outcomes in Resected Colon Cancer: A Single Centre Retrospective Analysis



Active Hexose Correlated Compound For Patients With Resectable/Borderline Resectable Pancreatic Cancer Treated By Neoadjuvant Therapy: A Study Protocol For A Double-Blind Randomized Phase II Trial



ABCC4, ITPA, NUDT15, TPMT and their interaction as genetic predictors of 6-mercaptopurine intolerance in chinese patients with acute lymphoblastic leukemia.



Dose intra-subject escalation to an event (DIETE): A new method for phase 1 dose-finding utilizing systematic intra-subject dose escalation with application to T-cell engagers.


More Dose Intensity 도즈 강도 sentence examples
10.1200/JCO.2021.39.15_SUPPL.8547

Elderly patients with unresectable stage 3 NSCLC treated with definitive chemoradiation with or without durvalumab: Safety and outcomes.



Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer–the Experience of a Tertiary Cancer Center



P337 Early infliximab clearance predicts remission in children with Crohn’s Disease



Exploiting gene mutations and biomarkers to guide treatment recommendations in mantle cell lymphoma



Analysis of ANC Levels after Filgrastim Therapy in Acute Leukemia Children with Neutropenia


More Dose Intensity 도즈 강도 sentence examples
10.1200/JCO.2019.37.4_SUPPL.251

Dose intensity of nab-paclitaxel and gemcitabine chemotherapy in metastatic pancreatic cancer.



ZANUBRUTINIB PLUS OBINUTUZUMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL) OR RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)


More Dose Intensity 도즈 강도 sentence examples
10.1158/2326-6074.CRICIMTEATIAACR18-A007

Abstract A007: Comparison of pretreatment conditioning on efficacy in two cohorts of a pilot study of genetically engineered NY-ESO-1c259T-cells in patients with synovial sarcoma



Tolerability of PCV in low grade glioma: A real world experience



Correlation between Skeletal Muscle Mass and Adverse Events of Neoadjuvant Chemotherapy in Patients with Gastric Cancer



Oral Complications in Children Undergoing Chemotherapy: The COMEDY (Clenching, Oral Mucositis, Eyes, DYsphagia) Pattern.



Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.



Toxicity and Response following CD19-specific CAR T cells in pediatric/young adult relapsed/refractory B-ALL.



Treatment Pattern and Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients in Indonesia: Part of Asia-Pacific Breast Initiative II


More Dose Intensity 도즈 강도 sentence examples
10.21320/2500-2139-2019-12-2-154-164

Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues



Development of an aperture-type radiation regulator for shielding against secondary radiation from x-ray tubes and collimators in computed tomography.



Novel Measures of Benzodiazepine and Z-Drug Utilisation Trends in a Canadian Provincial Adult Population (2001-2016).



Optical imaging method to quantify spatial dose variation due to the electron return effect in an MR-linac.



Non-conventional doses of somatostatin analogs in patients with progressing well differentiated neuroendocrine tumor.



Dose intensification of chemotherapy for early breast cancer in the age of de-escalation



Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses



Modeling Dose and Schedule Effects of AZD2811 Nanoparticles Targeting Aurora B Kinase for Treatment of Diffuse Large B-cell Lymphoma



Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia



BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population



Interpretation the Results of Adjuvant Chemotherapy in Curatively Resected Pancreatic Cancer


Learn more from Dose Intensity 도즈 강도

Dose Intensity 도즈 강도


Dose Intensity 도즈 강도
Encyclopedia 백과사전